Aspergillus-specific IgM/IgG antibody serostatus of patients hospitalized with moderate-critical COVID-19 in Uganda
African Health Sciences
; 22(3): 506-511, 2022-10-26. Tables
Article
en En
| AIM
| ID: biblio-1401811
Biblioteca responsable:
CG1.1
ABSTRACT
Invasive pulmonary aspergillosis is known to complicate the coronavirus diseases-2019 (COVID-19), especially those with critical illness. We investigated the baseline anti Aspergillus antibody serostatus of patients with moderate-critical COVID-19 hospitalized at 3 COVID-19 Treatment Units in Uganda. All 46 tested patients, mean age 30, and 11% with underlying respiratory disease had a negative serum anti-Aspergillus IgM/IgG antibody immunochromatographic test on day 3 (mean) of symptom onset (range 1-26), but follow up specimens to assess seroconversion were not available
Palabras clave
Texto completo:
1
Banco de datos:
AIM
Asunto principal:
Enfermedad Crítica
/
Aspergilosis Pulmonar Invasiva
/
COVID-19
País/Región como asunto:
Africa
Idioma:
En
Revista:
African Health Sciences
Año:
2022
Tipo del documento:
Article